AGA Family of Websites: Gastro.org
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
December 12, 2018

Abstracts announced for 2019 Gastrointestinal Cancers Symposium

Abstracts cover the esophagus and stomach, pancreas, small bowel and heptobility tract, and colon, rectum and anus. Join AGA, ASCO, ASTRO and SSO in San Francisco on Jan. 17-19, 2019.

Share on facebook
Share on twitter
Share on linkedin
Share on email

Abstract presentations have been announced for this year’s Gastrointestinal Cancers Symposium, which brings together clinicians and researchers from around the world to share the latest innovations in the treatment of gastrointestinal cancers. Learn about the latest research and multidisciplinary treatment strategies for GI malignancies by registering today.

 

Designed to maximize opportunities for podium presentation and research discussion, abstracts will be showcased in three Oral Abstract Sessions and Rapid Abstract Sessions. Daily Poster Sessions offer informal networking with attendees and researchers, as well as self-paced exploration of new research. Poster Walks, led by expert faculty, provide valuable opportunities for in-depth analysis of posters and research. The planning committee has selected a robust lineup of abstracts for presentation and a timely keynote lecture on immunotherapy. Topics for presentation and discussion include targeted molecular therapy, phase III studies on survival and safety, esophagectomy versus chemoradiotherapy, colorectal advancements with immunotherapy, and more.

 

Keynote Lecture

Immunotherapy—Lessons Learned from Melanoma for Application to GI Malignancies featuring Siwen Hu-Lieskovan, MD, PhD

 

Oral Abstract Highlights in Esophagus and Stomach

 

Abstract 3: Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric cancer (mGC) with or without prior gastrectomy: Results from a phase 3 study (TAGS). First Author: David H. Ilson, MD, PhD

 

Abstract 7: Parallel-group controlled trial of esophagectomy versus chemoradiotherapy in patients with clinical stage I esophageal carcinoma (JCOG0502). First Author: Ken Kato, MD, PhD

 

Oral Abstract Highlights in Pancreas, Small Bowel and Hepatobiliary Tract

 

Abstract 186: Analysis of survival and objective response (OR) in patients with hepatocellular carcinoma in a phase 3 study of lenvatinib (REFLECT). First Author: Masatoshi Kudo, MD, PhD

 

Abstract 188: Integrative molecular profiling and response to chemotherapy on the COMPASS trial. First Author: Grainne O’Kane, MB, BCh, BAO

 

Oral Abstract Highlights in Colon, Rectum and Anus

 

Abstract 480: A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results. First Author: Carl Christoph Schimanski, MD, PhD

 

Abstract 482: Adjuvant HIPEC in patients with colon cancer at high risk of peritoneal metastases: Primary outcome of the COLOPEC multicenter randomized trial. First Author: Charlotte Emma Louise Klaver, MD, BA

 

View the program for the full list of abstract titles, faculty, and session information. Don’t miss this opportunity to engage with colleagues and hear the latest updates. Register today and join AGA, ASCO, ASTRO and SSO in San Francisco for #GI9.

 

Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.